 | RAPT Therapeutics, Inc. | |||
| NGM : RAPT || Location: United States | ||||
$8.1+0.3 (+3.85%) |
0.29 M | 7.67 - 8.31 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 3.184 M |
| March 28, 2024 | 2.977 M |
| March 15, 2024 | 3.298 M |
| Feb. 29, 2024 | 2.487 M |
| Feb. 15, 2024 | 3.512 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.88 | -0.80 | 8.68% |
| 09/30/2023 | -0.77 | -0.82 | -6.73% |
| 06/30/2023 | -0.80 | -0.66 | 17.22% |
| 03/31/2023 | -0.69 | -0.76 | -9.57% |
| 12/31/2022 | -0.67 | -0.64 | 4.06% |
RAPT Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 34.800M | Shares Float | 27.505M |
| Short Float | 3.184M | Market Cap | 271.44M |
| Institution ownership | 0.00% | Insider ownership | 1.846% |
| Earnings Date | 05/08/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -3.05 | Forward EPS | -2.69 |